114 related articles for article (PubMed ID: 38171885)
1. Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy.
Yue L; Gong T; Jiang W; Qian L; Gong W; Sun Y; Cai X; Xu H; Liu F; Wang H; Li S; Zhu Y; Zheng Z; Wu Q; Guo T
Proteomics; 2024 Mar; 24(6):e2300242. PubMed ID: 38171885
[TBL] [Abstract][Full Text] [Related]
2. The proteome of clear cell ovarian carcinoma.
Ji JX; Cochrane DR; Negri GL; Colborne S; Spencer Miko SE; Hoang LN; Farnell D; Tessier-Cloutier B; Huvila J; Thompson E; Leung S; Chiu D; Chow C; Ta M; Köbel M; Feil L; Anglesio M; Goode EL; Bolton K; Morin GB; Huntsman DG
J Pathol; 2022 Dec; 258(4):325-338. PubMed ID: 36031730
[TBL] [Abstract][Full Text] [Related]
3. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
[TBL] [Abstract][Full Text] [Related]
4. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
Ceppi L; Grassi T; Galli F; Buda A; Aletti G; Lissoni AA; Adorni M; Garbi A; Colombo N; Bonazzi C; Landoni F; Fruscio R
Gynecol Oncol; 2021 Jan; 160(1):64-70. PubMed ID: 33077259
[TBL] [Abstract][Full Text] [Related]
5. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
Sprung RW; Brock JW; Tanksley JP; Li M; Washington MK; Slebos RJ; Liebler DC
Mol Cell Proteomics; 2009 Aug; 8(8):1988-98. PubMed ID: 19467989
[TBL] [Abstract][Full Text] [Related]
6. Parallel Reaction Monitoring-Mass Spectrometry (PRM-MS)-Based Targeted Proteomic Surrogates for Intrinsic Subtypes in Breast Cancer: Comparative Analysis with Immunohistochemical Phenotypes.
Park J; Oh HJ; Han D; Wang JI; Park IA; Ryu HS; Kim Y
J Proteome Res; 2020 Jul; 19(7):2643-2653. PubMed ID: 31755719
[TBL] [Abstract][Full Text] [Related]
7. High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.
Zhu Y; Weiss T; Zhang Q; Sun R; Wang B; Yi X; Wu Z; Gao H; Cai X; Ruan G; Zhu T; Xu C; Lou S; Yu X; Gillet L; Blattmann P; Saba K; Fankhauser CD; Schmid MB; Rutishauser D; Ljubicic J; Christiansen A; Fritz C; Rupp NJ; Poyet C; Rushing E; Weller M; Roth P; Haralambieva E; Hofer S; Chen C; Jochum W; Gao X; Teng X; Chen L; Zhong Q; Wild PJ; Aebersold R; Guo T
Mol Oncol; 2019 Nov; 13(11):2305-2328. PubMed ID: 31495056
[TBL] [Abstract][Full Text] [Related]
8. Detection of EWSR1 fusions in CCOC by targeted RNA-seq.
Rivera CM; Faquin WC; Thierauf J; Afrogheh AH; Jaquinet A; Iafrate AJ; Rivera MN; Troulis MJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):240-244. PubMed ID: 35165059
[TBL] [Abstract][Full Text] [Related]
9. Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics.
Kim YJ; Sweet SMM; Egertson JD; Sedgewick AJ; Woo S; Liao WL; Merrihew GE; Searle BC; Vaske C; Heaton R; MacCoss MJ; Hembrough T
J Proteome Res; 2019 Jan; 18(1):426-435. PubMed ID: 30481034
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma.
Eltabbakh GH; Mount SL; Beatty B; Simmons-Arnold L; Cooper K
J Surg Oncol; 2006 Apr; 93(5):379-86. PubMed ID: 16550573
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification.
Jia B; Zhao X; Wu D; Dong Z; Chi Y; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Chen X; Tian G; Long J; Yang X; Chen H; Wang J; Zhai X; Li S; Li J; Ma M; He Y; Kong L; Brcic L; Fang J; Wang Z
Transl Lung Cancer Res; 2021 Feb; 10(2):981-994. PubMed ID: 33718037
[TBL] [Abstract][Full Text] [Related]
13. Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library.
Qian L; Zhu J; Xue Z; Gong T; Xiang N; Yue L; Cai X; Gong W; Wang J; Sun R; Jiang W; Ge W; Wang H; Zheng Z; Wu Q; Zhu Y; Guo T
Mol Oncol; 2023 Aug; 17(8):1567-1580. PubMed ID: 36855266
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary.
Sue-A-Quan R; Patel PG; Shakfa N; Nyi MN; Afriyie-Asante A; Kang EY; Köbel M; Koti M
Gynecol Oncol; 2021 Aug; 162(2):421-430. PubMed ID: 34088514
[TBL] [Abstract][Full Text] [Related]
15. SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary.
Jiang T; Diao X; Ding M; Niu X; Wang C; Qi Y; Jia W; Pang L; Hu W; Zou H; Li F
J Mol Histol; 2021 Jun; 52(3):539-544. PubMed ID: 33608777
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of two methods for LC-MS/MS proteomic analysis of formalin fixed and paraffin embedded tissues.
Davalieva K; Kiprijanovska S; Dimovski A; Rosoklija G; Dwork AJ
J Proteomics; 2021 Mar; 235():104117. PubMed ID: 33453434
[TBL] [Abstract][Full Text] [Related]
17. Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms.
Huang D; Zhang H; Li L; Ge W; Liu W; Dong Z; Gao J; Yao N; Fu W; Huang L; Guo T; Sun Y; Teng X
Front Endocrinol (Lausanne); 2022; 13():854611. PubMed ID: 35923625
[TBL] [Abstract][Full Text] [Related]
18. Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry.
Scicchitano MS; Dalmas DA; Boyce RW; Thomas HC; Frazier KS
J Histochem Cytochem; 2009 Sep; 57(9):849-60. PubMed ID: 19471015
[TBL] [Abstract][Full Text] [Related]
19. Fertility sparing surgery for early-stage clear cell carcinoma of the ovary; A systematic review and analysis of obstetric outcomes.
Prodromidou A; Theofanakis C; Thomakos N; Haidopoulos D; Rodolakis A
Eur J Surg Oncol; 2021 Jun; 47(6):1286-1291. PubMed ID: 33509613
[TBL] [Abstract][Full Text] [Related]
20. Clear Cell Odontogenic Carcinoma: a Clinicopathological and Immunocytochemical Analysis.
Liu L; Zhang JW; Zhu NS; Zhu Y; Guo B; Yang XH
Pathol Oncol Res; 2020 Jul; 26(3):1559-1564. PubMed ID: 31482399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
